Guru P. Sonpavde: AACR⁩ – Many promising options for Phase I clinical trials

Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter:

“AACR24 ⁦AACR⁩ – Many promising options for Phase I clinical trials – searching for the best trials for our rapidly growing program AdventHealth Central Florida cancer Institute, Orlando, Florida– eager to explore collaborations!”

Source: Guru P. Sonpavde/X